KINETA, INC./DE (KANT)
Latest KANT Insider Trades
Keith Baker - OfficerDerivative247,933 sh- Keith Baker - OfficerDerivative2,663 sh
- Keith Baker - Officer
About KINETA, INC./DE (KANT)
KINETA, INC./DE files with the SEC under CIK 0001445283 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
90-Day SEC Filing Activity
No Form 4 activity for KANT in the last 90 days.
KANT Insider Transactions (Form 4)
6911 Form 4 filings on record, the earliest from Jun 23, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Keith Baker - Officer | Derivative | Common Stock | 247,933 |
KANT Insider Trading - FAQ
What is the latest insider trade for KANT?
KINETA, INC./DE (KANT) has filed no insider reports in the last 90 days. The most recent on record is dated 2025-06-30. The full record for KANT runs to 11 Form 4 filings, the earliest from 2025-06-23. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying KANT stock?
No insider purchases of KANT were filed in the last 90 days.
How many insiders are selling KANT stock?
No insider sales of KANT were filed in the last 90 days.
Where can I see KANT SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks KANT Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow KANT insider buys?
Create a free InsiderAlpha account and press Watch on this page to add KANT to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Keith Baker view on EDGAR
- - Kimberlee C. Drapkin view on EDGAR
- - Raymond J. Bartoszek view on EDGAR
- - Marion R. Foote view on EDGAR
- - Scott J. Dylla view on EDGAR
- - Richard Peters view on EDGAR
- - Shawn Iadonato view on EDGAR
- - David Arkowitz view on EDGAR
- - Craig W. Philips view on EDGAR
- - Thierry Guillaudeux view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where KANT's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track KANT insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
